‘A “fantasist” who posed as a doctor to dupe elderly people out of money and prescribed them potentially dangerous medicine, has been jailed.’
BBC News, 2nd May 2019
Source: www.bbc.co.uk
‘Caster Semenya’s enforced use of testosterone-limiting drugs is a potential human rights breach, legal experts claimed on Wednesday as they drew comparisons with the innate physical advantages of other world-dominating athletes.’
Daily Telegraph, 1st May 2019
Source: www.telegraph.co.uk
‘New rules to keep people safe when buying medications from online pharmacies have been described as a “big step forward” by Britain’s pharmacy regulator.’
BBC News, 16th April 2019
Source: www.bbc.co.uk
‘Neglect was a contributing factor in the death of a woman suffering from shingles who was given the wrong drug by a pharmacy, a coroner has ruled.’
BBC News, 3rd April 2019
Source: www.bbc.co.uk
‘Mice, fish, cats, dogs, horses, rabbits, monkeys – they’re all used in animal testing across the world.’
BBC News, 4th April 2019
Source: www.bbc.co.uk
‘Social media firms could be hit with new laws to stop them allowing the spread of anti-vaxxers’ myths online, the Health Secretary has said.’
Daily Telegraph, 26th March 2019
Source: www.telegraph.co.uk
‘The Mental Capacity Act code of practice must be updated to address issues around covert medication, human rights and social care, the Bar Council has said.’
Local Government Lawyer, 11th March 2019
Source: www.localgovernmentlawyer.co.uk
‘A London law firm is building what it says is the country’s first dedicated cannabis law practice as it looks to take the lead in a fast-growing market.’
Legal Futures, 18th February 2019
Source: www.legalfutures.co.uk
‘A government “hostile environment” for misclaimed free prescriptions and dental care is being scrutinised by auditors after it was claimed vulnerable patients are being fined £100 for ticking the wrong box on forms they struggle to read. The National Audit Office has announced it is “undertaking an investigation into penalty charge notices in healthcare”, including the numbers issued and whether they are overturned.
The Independent, 30th January 2019
Source: www.independent.co.uk
‘This was an appeal from the decision of the Court of Appeal in Warner-Lambert Company LLC v Generics (UK) Ltd (t/a Mylan) and Others [2016] EWCA Civ 1006 which I discussed in The Pregabalin Appeal: Generics v Warner-Lambert 17 Oct 2016. In that appeal, the Court of Appeal upheld the decision of Mr Justice Arnold in Generics (UK) Ltd (t/a Mylan) v Warner-Lambert Company LLC [2016] RPC 3, [2015] EWHC 2548 (Pat), [2015] CN 1499 which I blogged in The Pregabalin Trial: Generics (UK) Ltd v Warner-Lambert Company LLC 18 Sept 2015 and his refusal to allow the patent to be amended in Generics (UK) Ltd (t/a Mylan) v Warner-Lambert Company LLC [2016] RPC 16, [2015] EWHC 3370 (Pat).’
NIPC Law, 6th December 2018
Source: nipclaw.blogspot.com
‘Four people who manufactured and sold an unlicensed drug to patients suffering from conditions including cancer, multiple sclerosis, HIV and autism have been sentenced today (27 November).’
Crown Prosecution Service, 27th November 2018
Source: www.cps.gov.uk
‘The Supreme Court today dismissed an appeal by pharmaceutical company Pfizer, in a case that should provide clarity on patent law surrounding claims for new medical uses for a protected drug. In judgment handed down this morning the court allowed an appeal by generic drug makers Actavis and Mylan. The decision means Pfizer’s patent covering a second medical use for its product is invalid.’
Law Society's Gazette, 14th November 2018
Source: www.lawgazette.co.uk
‘The family of a six-year-old girl with cystic fibrosis who was denied funding for a breakthrough drug which could extend her life has launched a judicial review against the NHS.’
The Independent, 14th November 2018
Source: www.independent.co.uk
‘The UK government should consider changing patent law to incentivise major pharmaceutical companies to develop new antibiotics to address the “grave threat to health” posed by antimicrobial resistance (AMR), a committee of MPs has said.’
OUT-LAW.com, 1st November 2018
Source: www.out-law.com
‘Bayer Plc v NHS Darlington Clinical Commissioning Groups (CCG) and others [2018] EWHC 2465 (Admin). This judicial review concerned whether it was lawful for NHS clinical commissioning groups to adopt a policy for offering the drug Avastin to patients suffering from “wet” (or neo-vascular) age-related macular degeneration (AMD). Avastin, although not licensed for ophthalmic use, at £28 per injection is significantly cheaper than the licensed alternatives (£816 and £551 respectively per injection). The Royal College of Ophthalmologists has estimated that the NHS-wide saving of switching to Avastin was at least £102 million p.a.’
UK Human Rights Blog, 4th October 2018
Source: ukhumanrightsblog.com
‘The NHS has won a landmark battle against drug giants paving the way for the health service to save millions by prescribing cheaper medicine.’
Daily Telegraph, 21st September 2018
Source: www.telegraph.co.uk
‘The health care regulator is calling for greater powers to protect patients from online GPs after a struck-off doctor was discovered using a loophole to prescribe “unsafe” drugs.’
Daily Telegraph, 6th August 2018
Source: www.telegraph.co.uk
‘Currently, the law states that all abortion pills must be taken in a clinic or hospital – meaning some women end up having an abortion on public transport, or while driving home.’
Rights Info, 31st July 2018
Source: rightsinfo.org
‘Cases of Billy Caldwell and Alfie Dingley, who have severe epilepsy, along with lobbying, prompted change.’
The Guardian, 26th July 2018
Source: www.theguardian.com
‘The Home Secretary today announced a review into the scheduling of cannabis for medicinal purposes.’
Home Office, 19th June 2018
Source: www.gov.uk/home-office
© Inner Temple Library 2025